An early pilot trial suggests that combining atezolizumab (tecectriq) with rituximab (Rituxan), gemcitabine (gemzar) and ...
The Pullman Fire Department recently participated in a stair climb fundraiser organized by the Leukemia and Lymphoma Society.
Dr. Deepa Jagadeesh discusses Ordspono's potential FDA approval for relapsed/refractory follicular lymphoma, highlighting its manageable toxicity and low CRS rate.
EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...
The Scotia-Glenville Central School District says their team, “Rays of Hope,” is committed to the Leukemia and Lymphoma ...
In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...
T-cell lymphoma is a rare cancer that affects the lymphatic system. Learn about the types, signs, symptoms, treatments, and ...
Investing.com -- The European Commission has granted Bristol Myers (NYSE: BMY) Squibb, the biopharmaceutical company based in ...
14d
Verywell Health on MSN6 Symptoms of Dying of LymphomaLymphoma causes symptoms of organ failure before death. Learn what patients in palliative or hospice care could experience ...
By comparing tattoo patterns alongside cancer diagnoses, researchers found that people with tattoos have a higher occurrence ...
5d
News-Medical.Net on MSNGLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patientsResearchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
Living with follicular lymphoma, I challenge common misconceptions about cancer, highlighting the unique and varied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results